Natalizumab as a high-efficacy therapy with proven confirmed long-term effectiveness and a new, subcutaneous administration formula
Monika Adamczyk-Sowa
Affiliation and address for correspondenceMonika Adamczyk-Sowa
Affiliation and address for correspondence